Open house Arzneimittelrabattverträge Perampanel, ATC N03AX22
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Perampanel, ATC N03AX22
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
Agreements are non-exclusive and may be terminated automatically if a regular discount contract is awarded, reducing po...
Strict submission deadlines (3rd of month) and dual paper copies required if not using QES.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Jun 2028
- Provision of Perampanel (ATC N03AX22) pharmaceutical products under discounted pricing agreements
- Non-exclusive framework-like arrangement (open-house model) under §130a Abs. 8 SGB V
Show full summary
Open-house model for non-exclusive discount agreements on Perampanel (ATC N03AX22) with AOK Bayern. Any eligible pharmaceutical company can join at any time during the contract period (01.07.2026 – 30.06.2028) by submitting a signed declaration of reliability and the contract documents. No competitive selection, no estimated value disclosed.
Risks
Agreements are non-exclusive and may be terminated automatically if a regular discount contract is awarded, reducing po...
Strict submission deadlines (3rd of month) and dual paper copies required if not using QES.
Key Requirements
Technical
- Must be a pharmaceutical company
Administrative
- Submit signed declaration of reliability
- Submit signed contract and annex listing contract-covered pharmaceuticals
Buyer
Name
AOK Bayern - Die Gesundheitskasse
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open house Arzneimittelrabattverträge Perampanel, ATC N03AX22
Non-exclusive discount agreements for the active substance Perampanel. Contracts are identical for all participants, no individual negotiation. Automatic termination if a national/regional discount contract for the same substance comes into force.
Location
Duration
Category
Deadline
Award details
Selection criteria
Show original TED data
Original TED description
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich! BITTE BEACHTEN SIE: Die FRIST für einen Vertragsschluss zum nächsten Monatsersten endet jeweils am DRITTEN des Vormonats.
Procurement Details
- Publication date
- 17 May 2026
- Notice type
- Contract notice — standard
- Languages
- German
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 336749-2026
Documents (2)
Similar tenders
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Ganirelix (ATC-Code: H01CC01).
Czechia – Pharmaceutical products – Léčivý přípravek ATC skupiny R03DX05 s účinnou látkou OMALIZUMAB
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V über Arzneimittel mit dem Wirkstoff Denosumab Xgeva (ATC-Code nach WHO: M05BX04)
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination aus Formoterol und Beclometason, ausgenommen Dosieraerosole mit der Wirkstärke 100µg/6µg (ATC-Code: R03AK08).
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Moldova – Pharmaceutical products – Achiziționarea centralizată a Reagenților pentru Investigații Clinice, Hematologice și PATOLOGICE conform necesităților IMSP - beneficiari pentru anul 2027
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
Agreements are non-exclusive and may be terminated automatically if a regular discount contract is awarded, reducing po...
Strict submission deadlines (3rd of month) and dual paper copies required if not using QES.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications